baz-2通过调节乙胆代谢来增强体内的系统性蛋白质稳定
Christian Gallrein1, Ashley B Williams1, David H Meyer1
1Institute for Genome Stability in Aging and Disease, Medical Faculty, University and University Hospital of Cologne, Joseph-Stelzmann-Strasse 26, 50931 Cologne, Germany; Cologne Excellence Cluster for Cellular Stress Responses in Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC), University of Cologne, Joseph-Stelzmann-Strasse 26, 50931 Cologne, Germany.
Cell reports
|December 15, 2023
概括
在BAZ-2中发生突变,BAZ-2是一种与乙胆信号传递,反向蛋白质聚合和阿尔茨海默氏症和亨廷顿病模型中的神经毒性相关的基因. 这一发现为神经退行性疾病提供了新的治疗途径.
科学领域:
- 神经生物学 神经生物学 神经生物学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 像阿尔茨海默氏症 (AD) 和亨廷顿氏症 (HD) 这样的神经退行性疾病涉及蛋白质聚合物神经毒性.
- 胆性假设表明,乙胆 (ACh) 信号损失有助于AD病理,恢复作为治疗策略.
- ACh,蛋白质聚合和神经毒性之间的确切联系尚未完全理解,这阻碍了有效治疗的发展.
研究的目的:
- 为了研究BAZ-2的作用,人类BAZ2B的C. elegans Ortholog,在调节ACH信号传递.
- 确定调节BAZ-2是否可以影响AD和HD模型中的蛋白质聚合和神经毒性.
- 阐明BAZ-2调制的神经保护作用的基础机制.
主要方法:
- 使用了Caenorhabditis elegans (C. elegans) 模型用于阿尔茨海默病 (粉胺-β) 和亨廷顿病 (多重胺).
- 生成并分析了 baz-2 功能丧失突变 (Δbaz-2).
- 评估了蛋白质聚合,神经毒性,健康和寿命;研究了胆酸转移酶,ACH-酶和ACH受体的作用;检查了蛋白质稳定路径 (ER展开的蛋白质反应,无处不在的蛋白质酶系统).
主要成果:
- baz-2突变在C. elegans模型中逆转了粉样β和多重胺聚合和毒性.
- 在这些神经退行性模型中,Δbaz-2显著恢复了健康和寿命.
- 神经保护作用是由胆乙转移酶介导的,由ACh-酶耗尽模仿,并依赖于ACh受体.
- 减少BAZ-2或异卵性ACH治疗通过诱导内分泌网膜展开的蛋白质反应和全方位蛋白质酶体系统来增强蛋白质静止.
结论:
- BAZ-2 负面调节 ACh 信号,并有助于蛋白质聚合物神经毒性.
- 调节BAZ-2和ACH信号传递是神经退行性疾病的一种有前途的治疗策略.
- 准BAZ-2可以增强蛋白质稳定机制,为抗击蛋白质病变提供一种新的方法.
相关概念视频
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
676
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
676
01:24Phase II Reactions: Acetylation Reactions
231
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
231
01:26Anticholinesterase Agents: Poisoning and Treatment
873
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
873
01:22Cholinesterases: Distribution and Function
469
Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
469
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
128
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
128
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K